Myriad Genetics Ownership | Who Owns Myriad Genetics?

Myriad Genetics Ownership Summary

Myriad Genetics is owned by 112.92% institutional investors, 2.02% insiders. Blackrock is the largest institutional shareholder, holding 18.54% of MYGN shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 6.37% of its assets in Myriad Genetics shares.

MYGN Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Myriad Genetics	112.92%	2.02%	-14.94%
Sector	Healthcare Stocks	47.31%	8.01%	44.69%
Industry	Diagnostics & Research Stocks	48.43%	7.77%	43.80%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock	15.15M	18.54%	$370.59M
Vanguard group	10.06M	12.31%	$246.18M
Wellington management group llp	8.26M	10.11%	$202.10M
Camber capital management lp	5.50M	6.73%	$134.53M
State street	4.34M	5.31%	$106.25M
Earnest partners	4.07M	4.98%	$99.60M
Glenview capital management	3.75M	4.59%	$91.69M
Dimensional fund advisors lp	2.78M	3.40%	$67.92M
Bank of america corp /de/	2.71M	3.31%	$66.18M
Artisan partners limited partnership	2.53M	3.10%	$62.00M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Camber capital management lp	5.50M	3.72%	$134.53M
Glenview capital management	3.75M	1.80%	$91.69M
Oracle investment management	60.00K	1.37%	$1.47M
Essex investment management	240.13K	1.10%	$5.87M
Disciplined growth investors inc /mn	2.09M	0.96%	$51.06M
Oberweis asset management inc/	360.70K	0.54%	$8.82M
Earnest partners	4.07M	0.47%	$99.60M
Aimz investment advisors	39.59K	0.35%	$968.25K
Hillsdale investment management	151.18K	0.29%	$3.70M
Corton capital	17.18K	0.22%	$420.27K

Top Buyers

Holder	Shares	% Assets	Change
Loomis sayles & co l p	863.10K	0.03%	863.10K
Jpmorgan chase	573.72K	0.00%	468.85K
Oberweis asset management inc/	360.70K	0.54%	360.70K
Blackrock	15.15M	0.01%	271.49K
Essex investment management	240.13K	1.10%	240.13K

Top Sellers

Holder	Shares	% Assets	Change
Camber capital management lp	5.50M	3.72%	-2.13M
Glenview capital management	3.75M	1.80%	-1.20M
State street	4.34M	0.00%	-1.06M
Pictet asset management sa	543.49K	0.02%	-670.83K
State farm mutual automobile insurance	-	-	-446.06K

New Positions

Holder	Shares	% Assets	Change	Value
Loomis sayles & co l p	863.10K	0.03%	863.10K	$21.11M
Oberweis asset management inc/	360.70K	0.54%	360.70K	$8.82M
Essex investment management	240.13K	1.10%	240.13K	$5.87M
Mirae asset global etfs	213.06K	0.01%	213.06K	$5.21M
Trexquant investment lp	210.75K	0.08%	210.75K	$5.15M

Sold Out

Holder	Change
Mather group, llc.	-3.00
Nelson, van denburg & campbell wealth management group	-16.00
Johnson financial group	-36.00
Kelly financial services	-60.00
Cullen/frost bankers	-74.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2024	228	20.00%	92,294,010	-1.65%	112	0.86%	127	38.04%	63	-1.56%
Mar 31, 2024	190	-4.52%	93,842,573	4.39%	114	0.95%	92	-14.02%	64	8.47%
Dec 31, 2023	199	4.19%	89,898,490	8.71%	109	1.07%	107	25.88%	59	-15.71%
Sep 30, 2023	191	-0.52%	82,696,993	1.89%	101	1.03%	85	-2.30%	70	12.90%
Jun 30, 2023	192	-0.52%	81,166,964	-1.32%	99	0.97%	87	6.10%	62	-17.33%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
iShares Core S&P Small-Cap ETF	5.79M	6.37%	5.62K
Vanguard Explorer Inv	3.19M	3.52%	-744.87K
Vanguard Total Stock Mkt Idx Inv	2.70M	2.97%	2.75K
iShares Russell 2000 ETF	2.30M	2.54%	-5.18K
EARNEST Partners Smid Cap Core Founders	2.24M	2.47%	-11.52K
Vanguard Small Cap Index	2.16M	2.38%	-22.07K
Artisan Non-U.S. Small-Mid Growth Comp	1.58M	1.74%	-
Artisan International Small-Mid Investor	1.58M	1.74%	-
Vanguard Institutional Extnd Mkt Idx Tr	1.35M	1.49%	-44.23K
SPDR® S&P Biotech ETF	1.22M	1.34%	13.46K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Oct 11, 2024	DIAZ PAUL J	President and CEO	Sell	$343.95K
Sep 11, 2024	DIAZ PAUL J	President and CEO	Sell	$400.80K
Sep 11, 2024	Muzzey Dale	Chief Scientific Officer	Sell	$54.96K
Sep 09, 2024	Dreismann Heinrich	-	Sell	$270.52K
Sep 03, 2024	Reitan Colleen F	-	Sell	$1.29M

Insider Transactions Trends

Date	Buy	Sell
2024 Q4	-	1
2024 Q3	-	6
2024 Q2	-	6
2024 Q1	-	-
2023 Q4	-	2

MYGN Ownership FAQ

Who Owns Myriad Genetics?

Myriad Genetics shareholders are primarily institutional investors at 112.92%, followed by 2.02% insiders and -14.94% retail investors. The average institutional ownership in Myriad Genetics's industry, Diagnostics & Research Stocks, is 48.43%, which Myriad Genetics exceeds.

Who owns the most shares of Myriad Genetics?

Myriad Genetics’s largest shareholders are Blackrock (15.15M shares, 18.54%), Vanguard group (10.06M shares, 12.31%), and Wellington management group llp (8.26M shares, 10.11%). Together, they hold 40.96% of Myriad Genetics’s total shares outstanding.

Does Blackrock own Myriad Genetics?

Yes, BlackRock owns 18.54% of Myriad Genetics, totaling 15.15M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 370.59M$. In the last quarter, BlackRock increased its holdings by 271.49K shares, a 1.82% change.

Who is Myriad Genetics’s biggest shareholder by percentage of total assets invested?

Camber capital management lp is Myriad Genetics’s biggest shareholder by percentage of total assets invested, with 3.72% of its assets in 5.5M Myriad Genetics shares, valued at 134.53M$.

Who is the top mutual fund holder of Myriad Genetics shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of Myriad Genetics shares, with 6.37% of its total shares outstanding invested in 5.79M Myriad Genetics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools